Who owns Cubist Pharmaceuticals?

Key details on Cubist Pharmaceuticals (Ticker: CBST)

Who owns Cubist Pharmaceuticals?

Is CBST a good stock to own? Find out who bought Cubist Pharmaceuticals, who sold Cubist Pharmaceuticals (CBST) stock, and who holds a large position in Cubist Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 9.43M $625.27M Sept. 30, 2014
BNP PARIBAS ARBITRAGE, SNC 8.58M $2.11B March 31, 2014
PUTNAM INVESTMENTS 8.35M $553.98M Sept. 30, 2014
Wellington Management Company 5.41M $377.85M June 30, 2014
Vanguard 4.58M $304.06M Sept. 30, 2014
Westfield Capital Management Company 3.42M $226.98M Sept. 30, 2014
BlackRock Fund Advisors 3.11M $206.45M Sept. 30, 2014
T. Rowe Price Associates 2.29M $159.99M June 30, 2014
Barclays 2.18M $148.31M Dec. 31, 2013
STATE STREET CORPORATION 2.11M $140.27M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.11M $139.71M Sept. 30, 2014
Federated Investors 2.05M $136.17M Sept. 30, 2014
CALAMOS ADVISORS 1.92M $91.40M Sept. 30, 2012
HealthCor Management 1.90M $68.38M June 30, 2011
HAP Trading 1.90M $2.46M Dec. 31, 2013
Palo Alto Investors 1.84M $122.31M Sept. 30, 2014
Maverick Capital 1.74M $127.27M March 31, 2014
PointState Capital 1.65M $109.46M Sept. 30, 2014
Columbus Circle Investors 1.59M $63.15M Dec. 31, 2011
ALLIANCEBERNSTEIN 1.59M $105.67M Sept. 30, 2014
Damian Sousa 1.53M $112.16M March 31, 2014
Wells Fargo & Company 1.40M $89.17M Sept. 30, 2013
HealthCor Management 1.40M $96.42M Dec. 31, 2013
Deerfield Management Company 1.39M $95.47M Dec. 31, 2013
Canada Pension Plan Investment Board 1.37M $91.16M Sept. 30, 2014

Who sold Cubist Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Name Goodman & Company, Investment Counsel Dec. 31, 2011 1.68M $66.45M